Qingdao Riskell Biotechnology is reliable. According to relevant public information inquiries: Qingdao Ruishike Biotechnology Co., Ltd. was established on February 6, 2016. It is a private technology enterprise co-founded by R&D, production and sales experts. Since the company was established in 2016 Since then, the team of Qingdao Riskell Biotechnology Co., Ltd. has successively established immunoturbidity assay, enzyme-linked immunoassay and multiple microsphere flow immunofluorescence luminescence technology platforms, and obtained the national first-class medical device production registration certificate and 11 series Cytokine detection kit (multiple microsphere flow immunofluorescence luminescence method) Class I product registration number, applied to the State Food and Drug Administration and obtained 4 Class II diagnostic reagent classification numbers, and obtained 5 national software copyrights, It has 6 utility model patents and applied for 1 national invention patent. In 2017, the company was listed as a technology-based small and medium-sized enterprise by the Ministry of Science and Technology and Qingdao Qianfan Enterprise.